Clinical trials sponsored by Insel Gruppe AG, University Hospital Bern

Phase breakdown

Conditions studied

Recruiting trials led by Insel Gruppe AG, University Hospital Bern

• Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease
  NCT06386497 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations
• Administration of Intranasal Midazolam for Anxiety in Palliative Care
  NCT06330584 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
  NCT06629207 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• BrainAgeMS - a Comparative Study of Brain Aging in Healthy and Patients With Multiple Sclerosis
  NCT06221631 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
  NCT06954610 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
  NCT05976685 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 32 locations
• Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism
  NCT07143539 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Early Life Intervention in Pediatrics Supported by E-health - SMOKE
  NCT06311162 · Phase: Not applicable (e.g. observational or device study) · Ages: Up to 5 Years · Sex: All (male and female) · 1 location
• Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine
  NCT06951802 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 1 location
• Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
  NCT06659120 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Giving Children a Voice in Paediatric Anaesthesia
  NCT07524049 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female) · 7 locations
• Histological Assessment of Tissue Penetration Depth of Argon Beam Coagulation in Ovarian Endometriomas
  NCT07711743 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: Female · 1 location
• Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
  NCT05357781 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINOCA
  NCT05326828 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations
• Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions
  NCT04449523 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · 8 locations
• International Validation of Two Non-motor Scales in PD (NFS and SPARK)
  NCT04366804 · Phase: Not specified · Ages: 30 Years to 75 Years · Sex: All (male and female) · 8 locations
• LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure
  NCT04628078 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Longterm Functional Outcomes in Patients Undergoing Organ Preserving Treatment for Rectal Cancer With or Without Local Excision After Chemoradiotherapy
  NCT06249672 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study
  NCT07162831 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 16 Years · Sex: All (male and female) · 1 location
• Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
  NCT05955365 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study
  NCT06544148 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation
  NCT06892457 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• REducing SPEECH-related Side-effects of Deep Brain Stimulation in Parkinson's Disease Via Automated Speech Analysis
  NCT05182892 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease
  NCT05765110 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 75 Years · Sex: All (male and female) · 2 locations
• Swiss Diabetes Registry - SwissDiab Study
  NCT01179815 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• The Bern Rehab Registry
  NCT06516172 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• The Effect of an App-based Intervention on Quality of Life in Patients With Endometriosis.
  NCT06821217 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
  NCT06801899 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• Training Medical Residents in the Use of the Venous Excess UltraSound (VExUS) Score for Bedside Volume Assessment.
  NCT07541768 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 1 location

Common questions

How many trials is Insel Gruppe AG, University Hospital Bern recruiting for?

Insel Gruppe AG, University Hospital Bern is the lead sponsor of 29 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.